Cargando…
Low serum miR‐223 expression predicts poor outcome in patients with acute myeloid leukemia
BACKGROUND: Identification of biomarkers for acute myeloid leukemia (AML) is important for treating this malignancy. Recent studies have reported that microRNAs (miRNAs) are stably detectable in the blood/plasma and can be used as biomarkers for various types of cancer including AML. The aim of this...
Autores principales: | Yu, Guopan, Yin, Zhao, He, Han, Zheng, Zhongxin, Chai, Yanyan, Xuan, Li, Lin, Ren, Wang, Qiang, Li, Jie, Xu, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083432/ https://www.ncbi.nlm.nih.gov/pubmed/31691380 http://dx.doi.org/10.1002/jcla.23096 |
Ejemplares similares
-
Diagnostic value and significance of serum miR-132 combined with miR-223 for sepsis-induced cardiomyopathy
por: Li, Yanping, et al.
Publicado: (2021) -
Myeloid-Derived microRNAs, miR-223, miR27a, and miR-652, Are Dominant Players in Myeloid Regulation
por: Gilicze, Anna B., et al.
Publicado: (2014) -
The protective role of miR-223 in sepsis-induced mortality
por: Liu, Dan, et al.
Publicado: (2020) -
Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors
por: Hellberg, Teresa, et al.
Publicado: (2020) -
Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia
por: Tang, Xiaoqiong, et al.
Publicado: (2015)